Why Israel Understands Risk Better Than the World ft. Eldad Tamir of Finq
Most people think finance is complicated. Eldad Tamir, Founder of Finq, thinks it’s intentionally broken.
On this episode of IsraelTech, we sit down for a raw conversation about why the middle class is set up to lose and how AI is changing the future of wealth management.
Eldad explains how modern wealth management was built to serve the ultra-rich, why the middle class is pushed into bad financial products, and how human emotions quietly destroy long-term returns. We dive into psychology, Israeli risk-taking, the "B2C gap" in Israeli VC, and why Eldad believes we must remove humans from financial decision-making altogether.
Key Topics We Discuss:
- The Wealth Gap: Why premium financial services are reserved for the 1%.
- Human Error: Why fear and emotion matter more than intelligence in investing.
- The AI Revolution: How Finq uses data to remove human bias.
- The Israeli Edge: What Israel understands about risk that the rest of the world misses.
- Future Tech: Eldad’s take on Neuralink and the evolution of human decision-making.
Shorts of the Week
End of Cohort #2 of the Flagship Program with our partners at Ignite DeepTech.
Most AI fear online is aimed at the wrong target. ft. Ori Goshen of AI21 Labs
Israel’s Air Force doesn’t have the luxury of doing just one thing. ft. Chemi Peres of Pitango
It can feel like culture shock, but give it time ft. Jason Wolf of IronNation
This Week in Israeli Tech News
Converge Bio is an Israeli life sciences startup building validated generative AI systems that plug directly into real biotech and pharma workflows, bridging the gap between cutting-edge AI research and day-to-day scientific execution.
What makes this milestone stand out is the company’s focus on usability and proof. Beyond proprietary models, Converge has developed AI platforms that scientists actively use today, with paying customers and demonstrated impact across biomarker discovery, drug development, and manufacturing.
Strong momentum, deep scientific validation, and real-world adoption position Converge Bio as a serious contender to become the generative AI backbone of the life sciences industry.
Congratulations to founders Dov Gertz, Iddo Weiner, Oded Kalev, and the entire Converge Bio team as they scale the platform and push AI-driven drug discovery forward.
Torq is redefining security operations with the world’s first true AI SOC platform, built around autonomous, agentic AI that replaces legacy SIEM and SOAR workflows.
Novee emerged from stealth with one of the fastest Series A rounds in offensive security, introducing a proprietary AI-driven penetration testing platform that operates at attacker speed.
Israeli startup Seraphic, founded by Ilan Yeshua (CEO), Avihay Cohen (CTO), and Suresh Batchu (COO), is becoming a core part of CrowdStrike’s next-generation identity and access strategy.
Klearly is building a hospitality-first payments platform that integrates directly into existing POS systems, removing friction for restaurants, bars, and clubs.
Our Replies Are OPEN!
We love hearing from you! Got a comment on a video? A news tip we should highlight? Drop us a message - your voice is crucial in helping us democratize the Israeli tech ecosystem, and we’re listening!
More from IsraelTech
